TA
Tiedemann Advisors Portfolio holdings
AUM
$2.33B
1-Year Return
15.56%
This Quarter Return
+1.09%
1 Year Return
+15.56%
3 Year Return
+31.51%
5 Year Return
+38.36%
10 Year Return
+102.1%
AUM
$2B
AUM Growth
-$126M
(-5.9%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-7.27%
Top 10 Holdings %
Top 10 Hldgs %
47.78%
Holding
454
New
11
Increased
73
Reduced
171
Closed
164
Top Buys
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
$92.1M |
| 2 |
Acquirers Small and Micro Deep Value ETF
DEEP
|
$12M |
| 3 |
Verizon
VZ
|
$11.6M |
| 4 |
iShares Core Moderate Allocation ETF
AOM
|
$10M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$5.52M |
Top Sells
| 1 |
Molina Healthcare
MOH
|
$12.6M |
| 2 |
Vanguard FTSE Pacific ETF
VPL
|
$9.86M |
| 3 |
APU
AmeriGas Partners, L.P.
APU
|
$9.48M |
| 4 |
Microsoft
MSFT
|
$8.49M |
| 5 |
Apple
AAPL
|
$8.45M |
Sector Composition
| 1 | Energy | 18.26% |
| 2 | Technology | 8.56% |
| 3 | Utilities | 6.17% |
| 4 | Communication Services | 2.88% |
| 5 | Healthcare | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
SEI Investments
SEIC
$10.8B
| $264K | 0.01% |
4,704
-6,158
| -57% | -$346K |
|
|
UN
252
DELISTED
Unilever NV New York Registry Shares
UN
| $260K | 0.01% |
4,282
-7,249
| -63% | -$440K |
|
253
Broadcom
AVGO
$1.58T
| $252K | 0.01% |
8,690
-18,790
| -68% | -$545K |
|
254
Edwards Lifesciences
EW
$47.5B
| $252K | 0.01% |
4,098
-24,720
| -86% | -$1.52M |
|
255
Sempra
SRE
$52.9B
| $252K | 0.01% |
3,668
-72
| -2% | -$4.95K |
|
256
Rogers Communications
RCI
$19.4B
| $250K | 0.01% |
4,651
+824
| +22% | +$44.3K |
|
257
Cognex
CGNX
$7.55B
| $249K | 0.01% |
5,200
-9,580
| -65% | -$459K |
|
258
Kimberly-Clark
KMB
$43.1B
| $245K | 0.01% |
1,827
-3,772
| -67% | -$506K |
|
|
APRN
259
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $245K | 0.01% |
3,025
+1,111
| +58% | +$90K |
|
260
iShares Core 60/40 Balanced Allocation ETF
AOR
$2.69B
| $243K | 0.01% |
5,274
| – | – |
|
261
CVS Health
CVS
$93.6B
| $238K | 0.01% |
4,385
-24,138
| -85% | -$1.31M |
|
262
MetLife
MET
$52.9B
| $238K | 0.01% |
4,791
-1,189
| -20% | -$59.1K |
|
263
Materials Select Sector SPDR Fund
XLB
$5.52B
| $238K | 0.01% |
4,070
| – | – |
|
264
Idexx Laboratories
IDXX
$51.4B
| $234K | 0.01% |
850
-4,174
| -83% | -$1.15M |
|
265
Booking.com
BKNG
$178B
| $233K | 0.01% |
124
-106
| -46% | -$199K |
|
266
Qualcomm
QCOM
$172B
| $233K | 0.01% |
3,076
-412
| -12% | -$31.2K |
|
267
CME Group
CME
$94.4B
| $227K | 0.01% |
1,170
-8,786
| -88% | -$1.7M |
|
268
Wabtec
WAB
$33B
| $227K | 0.01% |
3,189
-1,767
| -36% | -$126K |
|
269
Baxter International
BAX
$12.5B
| $225K | 0.01% |
2,735
+15
| +0.6% | +$1.23K |
|
270
SolarEdge
SEDG
$2.04B
| $224K | 0.01% |
+3,582
| New | +$224K |
|
271
Invesco Fundamental High Yield Corporate Bond ETF
PHB
$354M
| $223K | 0.01% |
11,796
+1,070
| +10% | +$20.2K |
|
272
Accenture
ACN
$159B
| $222K | 0.01% |
1,203
-9,758
| -89% | -$1.8M |
|
273
Vanguard FTSE Europe ETF
VGK
$26.9B
| $220K | 0.01% |
4,010
| – | – |
|
274
Regeneron Pharmaceuticals
REGN
$60.8B
| $218K | 0.01% |
695
-476
| -41% | -$149K |
|
275
AtriCure
ATRC
$1.76B
| $217K | 0.01% |
+7,263
| New | +$217K |
|